<DOC>
	<DOCNO>NCT01361308</DOCNO>
	<brief_summary>The purpose study ass safety &amp; efficacy Brisdelle ( paroxetine mesylate ) Capsules 7.5 mg treatment vasomotor symptom ( VMS ) associate menopause .</brief_summary>
	<brief_title>Efficacy/Safety Study Brisdelle™ ( Formerly Known Mesafem ) Treatment Vasomotor Symptoms ( VMS )</brief_title>
	<detailed_description>This 12-week , multicenter , double-blind , randomize , placebo-controlled study Brisdelle ( paroxetine mesylate ) Capsules 7.5 mg placebo capsule subject moderate severe postmenopausal VMS , define follow : - Moderate VMS : Sensation heat sweating , able continue activity - Severe VMS : Sensation heat sweating , cause cessation activity The study comprise screening period , run-in period , baseline visit , double-blind treatment period .</detailed_description>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>1 . Female , ≥ 40 year age screening ( inclusive ) 2 . Reported 78 moderate severe hot flash per day ( average ) 5060 moderate severe hot flash per week least 30 day prior screen visit 3 . Spontaneous amenorrhea least 12 consecutive month 4 . Amenorrhea least 6 month meet biochemical criterion menopause 5 . Bilateral salpingooophorectomy ≥ 6 week without hysterectomy 1 . Known nonresponder previous Selective serotonin reuptake inhibitor ( SSRI ) Serotonin norepinephrine reuptake inhibitor ( SNRI ) treatment VMS 2 . History self injurious behavior 3 . History clinical diagnosis depression treatment depression 4 . History clinical diagnosis borderline personality disorder 5 . Use investigational study medication within 30 day prior screen study 6 . Concurrent participation another clinical trial previous participation trial 7 . Family investigationalsite staff</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Vasomotor Symptoms</keyword>
	<keyword>Hot Flashes Perimenopause</keyword>
	<keyword>Climacteric Symptoms</keyword>
	<keyword>Mesafem</keyword>
	<keyword>Low-Dose Mesylate salt Paroxetine ( LDMP )</keyword>
</DOC>